GAM Holding’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10,527
Closed -$544K 308
2021
Q1
$544K Buy
+10,527
New +$521K 0.03% 258
2020
Q4
Sell
-21,600
Closed -$756K 272
2020
Q3
$756K Hold
21,600
0.05% 257
2020
Q2
$1.16M Hold
21,600
0.07% 233
2020
Q1
$766K Hold
21,600
0.05% 250
2019
Q4
$1.03M Hold
21,600
0.05% 282
2019
Q3
$700K Hold
21,600
0.03% 484
2019
Q2
$1.08M Hold
21,600
0.04% 470
2019
Q1
$1.46M Hold
21,600
0.06% 320
2018
Q4
$996K Sell
21,600
-2,600
-11% -$160K 0.05% 353
2018
Q3
$1.87M Hold
24,200
0.07% 302
2018
Q2
$2.04M Hold
24,200
0.07% 283
2018
Q1
$1.98M Hold
24,200
0.07% 288
2017
Q4
$1.38M Buy
+24,200
New +$1.52M 0.04% 483
2017
Q3
Sell
-10,000
Closed -$515K 532
2017
Q2
$515K Buy
10,000
+3,000
+43% +$153K 0.01% 785
2017
Q1
$409K Hold
7,000
0.01% 844
2016
Q4
$292K Hold
7,000
0.01% 883
2016
Q3
$370K Sell
7,000
-32,400
-82% -$1.41M 0.01% 781
2016
Q2
$1.65M Buy
39,400
+3,700
+10% +$183K 0.03% 565
2016
Q1
$1.45M Sell
35,700
-10,000
-22% -$428K 0.02% 554
2015
Q4
$2.97M Buy
45,700
+31,000
+211% +$2.03M 0.05% 392
2015
Q3
$1.04M Buy
14,700
+10,900
+287% +$1.07M 0.02% 679
2015
Q2
$422K Buy
+3,800
New +$409K 0.01% 887

Other funds holding AGIO

GAM Holding's AGIO Position: Q2 2021 in Review

GAM Holding sold out of Agios Pharmaceuticals (AGIO) in Q2 2021, closing a stake of 10,527 shares — an estimated $544K sold.

GAM Holding first reported a position in AGIO in Q2 2015 and held it in 22 quarters. The position peaked at $2.97M in Q4 2015. 186 funds tracked by Wall St. Rank hold AGIO as of Q2 2021.

  • GAM Holding reported no remaining Agios Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • GAM Holding sold 10,527 Agios Pharmaceuticals shares in Q2 2021, an estimated $544K.
  • GAM Holding first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 22 quarters.
  • GAM Holding's Agios Pharmaceuticals position peaked at $2.97M in Q4 2015.
  • 186 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2021.

Based on GAM Holding's 13F filing for Q2 2021, filed 9 Aug 2021.